查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1462642

2030 年胍丁胺市場預測：按形式、銷售管道、應用和地區進行的全球分析

Agmatine Market Forecasts to 2030 - Global Analysis By Form, Sales Channel, Application and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據Stratistics MRC的數據，2023年全球胍丁胺市場規模為5,970萬美元，預計2030年將達到1.216億美元，預測期內年複合成長率為10.7%。

胍丁胺市場是指硫酸胍丁胺的全球貿易和消費量，硫酸胍丁胺是一種源自氨基酸精氨酸的化合物。胍丁胺因其潛在的健康益處而受到關注，包括提高運動表現、控制疼痛和支持認知功能。由於它有望具有神經保護作用，因此被視為治療神經病變疼痛和憂鬱症神經系統疾病的有前途的藥物。

根據世界衛生組織（WHO）統計，慢性病佔全球整體死亡人數的74%，每年約造成4,100萬人死亡，其中約1,700萬人在70歲前死亡。

運動和健身活動的受歡迎程度

體育和健身活動的流行是胍丁胺市場的促進因素，因為人們認為胍丁胺在提高運動表現和恢復方面具有好處。運動員和健身愛好者不斷尋找最佳化訓練方案和提高身體表現的方法，導致對胍丁胺等補充品的需求增加。胍丁胺對這一人群特別有吸引力，因為它據稱能夠增加一氧化氮的產生、改善血流量、增強耐力和肌肉泵。此外，隨著人們越來越注重實現健身目標和維持整體健康，將營養補充食品日常生活的趨勢日益明顯，進一步推動了對胍丁胺產品的需求。

價格敏感度

與其他營養補充相比，胍丁胺的售價通常較高，這可能會阻止對價格敏感的消費者定期購買它。這種定價動態可能會限制市場的成長潛力，特別是對於在醫療保健支出中優先考慮成本效益的消費者而言。胍丁胺產品可能難以在市場上普及接受，因為市場上可以以較低的價格獲得類似有效的替代品。然而，胍丁胺市場的製造商和負責人面臨著平衡產品品質和功效與承受能力的挑戰，以吸引更廣泛的消費者群體。

重視預防保健

隨著人們越來越認知到保持最佳健康對於預防疾病和促進長壽的重要性，人們對胍丁胺等補充品的興趣似乎與日俱增，其健康益處似乎超出了基本營養攝入。胍丁胺的神經保護特性及其在維持心血管健康、疼痛管理和認知增強方面的作用，與預防保健的目標一致。在尋找改善整體健康和降低慢性病風險的方法時，營養補充食品成為醫療保健的補充方法。

有限的臨床證據

儘管初步研究表明其具有潛在的健康益處，例如神經保護、疼痛管理和認知增強，但缺乏強力的臨床試驗或全面研究表明其有效性可能不確定，其安全性和有效性仍存在不確定性。如果沒有足夠的科學檢驗，消費者、醫療保健專業人員和監管機構可能在推薦或核准胍丁胺產品時保持謹慎態度，這可能會限制市場成長。然而，缺乏確鑿的證據可能會讓潛在消費者持懷疑態度，並阻止他們投資胍丁胺補充品。

COVID-19 的影響：

隨著消費者健康意識的增強並專注於增強免疫力，對食品胍丁胺的營養補充的需求正在迅速增加。這一趨勢是由對維持整體健康和抵禦病毒的能力的擔憂所推動的。疫情也擾亂了全球供應鏈和製造營運，為原料採購和最終產品製造帶來了挑戰。然而，經濟的不確定性和消費者支出模式的變化正在影響購買行為，有些人優先考慮必需品而不是營養補充等可自由支配的購買。

預計粉末細分市場在預測期內將是最大的

由於其便利性和多功能性，粉末細分市場預計將在預測期內佔據最大的市場佔有率，使消費者可以輕鬆地將其混合到飲料中或將其納入食譜中，以滿足不同的偏好和生活方式。這種易用性增加了胍丁胺產品的吸引力，特別是對於尋求一種簡單且可自訂的方式將營養補充食品日常生活的個人而言。此外，粉末配方通常比其他型態含有更高濃度的胍丁胺，使其更具成本績效，並可能吸引注重成本的消費者。

預計藥局產業在預測期內年複合成長率最高。

預計藥局業務在整個管制期間將保持盈利成長。胍丁胺將越來越受到尋求天然替代品的消費者的追捧，因為該細分市場因其潛在的健康益處（包括緩解疼痛、增強情緒和改善認知功能）而獲得認可。藥局利用其廣泛的影響力和消費者的信任，積極庫存和促銷胍丁胺產品，從而推動需求。

比例最高的地區：

良好的監管標準、對食品營養補充和營養成分法的修訂以促進其使用和消費，以及更加重視探索神經保護和改善情緒特性的產品的潛力，預計將導致亞太地區在預測期內實現成長。最大的市場佔有率。在這些特性不斷增加的地區，對含有胍丁胺的產品的需求可能會受到 GDP 成長率、可支配收入水準和消費者購買模式等經濟因素的影響。

年複合成長率最高的地區：

預計亞太地區在預測期內將出現良好的成長。監管機構越來越認知到胍丁胺在藥品、營養補充和農業中的安全性和有效性，增加了製造商和消費者的信心。簡化的核准流程和明確的胍丁胺使用指南使得將胍丁胺納入產品中變得更加容易，從而推動了該地區的市場成長。此外，旨在促進該地區研究和創新的支持政策鼓勵了對胍丁胺相關研發活動的投資，從而促進了新應用和生產方法的開發。

提供免費客製化：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次研究資料
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 應用分析
  • 新興市場
  • COVID-19 的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球胍丁胺市場：依形狀分類

  • 膠囊
  • 粉末

第6章全球胍丁胺市場：依銷售管道分類

  • 專賣店
  • 藥局
  • 保健/美容店
  • 第三方線上通路
  • 其他銷售管道

第7章全球胍丁胺市場：依應用分類

  • 補充品和營養補充食品
  • 製藥
  • 其他用途

第8章全球胍丁胺市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第9章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第10章 公司概況

  • Ajinomoto Co., Inc
  • Douglas Laboratories
  • Dymatize Nutrition
  • Glanbia Nutritionals
  • Jarrow Formulas
  • Metabolic Maintenance
  • NOW Foods Inc
  • Nutrabio Inc
  • Prinova Group LLC
  • Swanson Health
Product Code: SMRC25693

According to Stratistics MRC, the Global Agmatine Market is accounted for $59.7 million in 2023 and is expected to reach $121.6 million by 2030 growing at a CAGR of 10.7% during the forecast period. The agmatine market refers to the global trade and consumption of agmatine sulfate, a compound derived from the amino acid arginine. Agmatine has gained attention for its potential health benefits, including its role in enhancing athletic performance, managing pain, and supporting cognitive function. It is utilized for its potential neuroprotective properties, making it a promising candidate for the treatment of neurological disorders like neuropathic pain and depression.

According to the World Health Organization, chronic diseases are the major cause of death globally with around 41 million deaths each year equivalent to 74% of total deaths globally, and around 17 million out of these deaths take place before age 70.

Market Dynamics:

Driver:

Popularity of sports and fitness activities

The popularity of sports and fitness activities serves as a driver of the agmatine market due to the compound's perceived benefits in enhancing athletic performance and recovery. Athletes and fitness enthusiasts are continually seeking ways to optimize their training regimens and improve their physical capabilities, leading to a growing demand for supplements like agmatine. Agmatine's purported ability to increase nitric oxide production, improve blood flow, and enhance endurance and muscle pump makes it particularly attractive to this demographic. Moreover, as individuals become increasingly focused on achieving their fitness goals and maintaining overall well-being, they are more inclined to incorporate nutritional supplements into their routines, further propelling the demand for agmatine products.

Restraint:

Price sensitivity

Agmatine often come at a premium price compared to other nutritional products, which can deter price-conscious consumers from purchasing them regularly. This pricing dynamic may limit the market's growth potential, especially among individuals who prioritize cost-effectiveness in their healthcare spending. In markets where alternatives offering similar benefits are available at lower prices, agmatine products may struggle to gain traction. However, manufacturers and marketers in the agmatine market face the challenge of balancing product quality and efficacy with affordability to appeal to a broader consumer base.

Opportunity:

Focus on preventive healthcare

With rising awareness of the importance of maintaining optimal health to prevent diseases and promote longevity, there's a growing interest in supplements like agmatine that offer potential health benefits beyond basic nutrition. Agmatine's purported neuroprotective properties, along with its role in supporting cardiovascular health, managing pain, and enhancing cognitive function, align well with the goals of preventive healthcare. As individuals seek ways to enhance their overall well-being and reduce the risk of chronic conditions, they are turning to dietary supplements as a complementary approach to their healthcare regimen.

Threat:

Limited clinical evidence

While preliminary research suggests potential health benefits, including neuroprotection, pain management, and cognitive enhancement, the lack of robust clinical trials and comprehensive studies leaves uncertainties regarding its efficacy and safety. Without sufficient scientific validation, consumers, healthcare professionals, and regulatory bodies may remain cautious about recommending or approving agmatine products, limiting market growth. However, the absence of conclusive evidence may lead to skepticism among potential consumers, deterring them from investing in agmatine supplements.

Covid-19 Impact:

There has been a surge in demand for dietary supplements, including agmatine, as consumers have become increasingly health-conscious and focused on boosting their immunity. This trend has been driven by concerns about maintaining overall wellness and resilience against the virus. The pandemic has also disrupted global supply chains and manufacturing operations, leading to challenges in sourcing raw materials and producing finished products. However, economic uncertainties and changes in consumer spending patterns have influenced purchasing behaviors, with some individuals prioritizing essential goods over discretionary purchases like dietary supplements.

The powder segment is expected to be the largest during the forecast period

Powder segment is prophesied to witness the largest share of the market during the overcast period as it offers convenience and versatility, allowing consumers to easily mix them into beverages or incorporate them into recipes, catering to diverse preferences and lifestyles. This ease of use enhances the appeal of agmatine products, particularly among individuals seeking simple and customizable ways to integrate nutritional supplements into their daily routines. Additionally, powdered formulations often provide higher concentrations of agmatine per serving compared to other formats, offering better value for money and potentially attracting cost-conscious consumers.

The drug stores segment is expected to have the highest CAGR during the forecast period

Drug Stores segment is positioned to hold profitable growth throughout the domination period. As agmatine gains recognition in this segment for its potential health benefits, such as pain relief, mood enhancement, and cognitive improvement, it becomes increasingly sought after by consumers looking for natural alternatives. Drug stores, leveraging their widespread presence and consumer trust, actively stock and promote agmatine products, thereby driving demand.

Region with largest share:

Due to favorable regulatory standards, changes in laws pertaining to dietary supplements and nutritional ingredients that promote their use and consumption, and a growing emphasis on examining the product's potential for neuroprotective and mood-enhancing properties, the Asia-Pacific region is anticipated to hold the largest share during the projection period. The demand for products containing agmatine in the region where these characteristics are increasing can be influenced by economic factors such as GDP growth, levels of disposable income, and consumer purchasing patterns.

Region with highest CAGR:

Asia Pacific is expected to witness lucrative growth over the extrapolated period. Regulatory bodies are increasingly acknowledging the safety and efficacy of agmatine in pharmaceuticals, dietary supplements, and agriculture, which is instilling confidence among manufacturers and consumers alike. Streamlined approval processes and clear guidelines regarding the use of agmatine are facilitating its incorporation into products, thereby driving market growth in the region. Additionally, supportive policies aimed at promoting research and innovation in the region is encouraging investment in R&D activities related to agmatine, leading to the development of new applications and production methods.

Key players in the market

Some of the key players in Agmatine market include Ajinomoto Co., Inc, Douglas Laboratories, Dymatize Nutrition, Glanbia Nutritionals, Jarrow Formulas, Metabolic Maintenance, NOW Foods Inc, Nutrabio Inc, Prinova Group LLC and Swanson Health.

Key Developments:

In August 2023, Hi-Tech Pharmaceuticals, unveiled its new KRANK3D pre-workout supplement, that utilizes the novel approach called Arginase Inhibition. It is mainly designed to accelerate muscle growth through creating a feeding pool flourishing with compounds.

In April 2023, Bucked Up, a leading sports nutrition and lifestyle brand, announced the launch of a first-of-its-kind pre-workout product called Pixie Pump. The newly developed product includes agmatine, nitrosigine, Vitamin B6, Vitamin B12, and Himalayan rock salt, and is free from caffeine.

In January 2022, Dr. Riggs Rhelief, introduced its new revolutionary functional herbal beverage powder, which offers significant pain relief within just a few minutes and is also quickly absorbed into the bloodstream. The newly launched beverage contains the amino acid arginine, which is metabolized into agmatine and ornithine, resulting in less nerve pain.

Forms Covered:

  • Capsules
  • Powder

Sales Channels Covered:

  • Specialty Stores
  • Drug Stores
  • Health & Beauty Stores
  • Third-party Online Channels
  • Other Sales Channels

Applications Covered:

  • Supplements & Nutraceuticals
  • Pharmaceutical
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Agmatine Market, By Form

  • 5.1 Introduction
  • 5.2 Capsules
  • 5.3 Powder

6 Global Agmatine Market, By Sales Channel

  • 6.1 Introduction
  • 6.2 Specialty Stores
  • 6.3 Drug Stores
  • 6.4 Health & Beauty Stores
  • 6.5 Third-party Online Channels
  • 6.6 Other Sales Channels

7 Global Agmatine Market, By Application

  • 7.1 Introduction
  • 7.2 Supplements & Neutraceuticals
  • 7.3 Pharmaceutical
  • 7.4 Other Applications

8 Global Agmatine Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Ajinomoto Co., Inc
  • 10.2 Douglas Laboratories
  • 10.3 Dymatize Nutrition
  • 10.4 Glanbia Nutritionals
  • 10.5 Jarrow Formulas
  • 10.6 Metabolic Maintenance
  • 10.7 NOW Foods Inc
  • 10.8 Nutrabio Inc
  • 10.9 Prinova Group LLC
  • 10.10 Swanson Health

List of Tables

  • Table 1 Global Agmatine Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Agmatine Market Outlook, By Form (2021-2030) ($MN)
  • Table 3 Global Agmatine Market Outlook, By Capsules (2021-2030) ($MN)
  • Table 4 Global Agmatine Market Outlook, By Powder (2021-2030) ($MN)
  • Table 5 Global Agmatine Market Outlook, By Sales Channel (2021-2030) ($MN)
  • Table 6 Global Agmatine Market Outlook, By Specialty Stores (2021-2030) ($MN)
  • Table 7 Global Agmatine Market Outlook, By Drug Stores (2021-2030) ($MN)
  • Table 8 Global Agmatine Market Outlook, By Health & Beauty Stores (2021-2030) ($MN)
  • Table 9 Global Agmatine Market Outlook, By Third-party Online Channels (2021-2030) ($MN)
  • Table 10 Global Agmatine Market Outlook, By Other Sales Channels (2021-2030) ($MN)
  • Table 11 Global Agmatine Market Outlook, By Application (2021-2030) ($MN)
  • Table 12 Global Agmatine Market Outlook, By Supplements & Neutraceuticals (2021-2030) ($MN)
  • Table 13 Global Agmatine Market Outlook, By Pharmaceutical (2021-2030) ($MN)
  • Table 14 Global Agmatine Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 15 North America Agmatine Market Outlook, By Country (2021-2030) ($MN)
  • Table 16 North America Agmatine Market Outlook, By Form (2021-2030) ($MN)
  • Table 17 North America Agmatine Market Outlook, By Capsules (2021-2030) ($MN)
  • Table 18 North America Agmatine Market Outlook, By Powder (2021-2030) ($MN)
  • Table 19 North America Agmatine Market Outlook, By Sales Channel (2021-2030) ($MN)
  • Table 20 North America Agmatine Market Outlook, By Specialty Stores (2021-2030) ($MN)
  • Table 21 North America Agmatine Market Outlook, By Drug Stores (2021-2030) ($MN)
  • Table 22 North America Agmatine Market Outlook, By Health & Beauty Stores (2021-2030) ($MN)
  • Table 23 North America Agmatine Market Outlook, By Third-party Online Channels (2021-2030) ($MN)
  • Table 24 North America Agmatine Market Outlook, By Other Sales Channels (2021-2030) ($MN)
  • Table 25 North America Agmatine Market Outlook, By Application (2021-2030) ($MN)
  • Table 26 North America Agmatine Market Outlook, By Supplements & Neutraceuticals (2021-2030) ($MN)
  • Table 27 North America Agmatine Market Outlook, By Pharmaceutical (2021-2030) ($MN)
  • Table 28 North America Agmatine Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 29 Europe Agmatine Market Outlook, By Country (2021-2030) ($MN)
  • Table 30 Europe Agmatine Market Outlook, By Form (2021-2030) ($MN)
  • Table 31 Europe Agmatine Market Outlook, By Capsules (2021-2030) ($MN)
  • Table 32 Europe Agmatine Market Outlook, By Powder (2021-2030) ($MN)
  • Table 33 Europe Agmatine Market Outlook, By Sales Channel (2021-2030) ($MN)
  • Table 34 Europe Agmatine Market Outlook, By Specialty Stores (2021-2030) ($MN)
  • Table 35 Europe Agmatine Market Outlook, By Drug Stores (2021-2030) ($MN)
  • Table 36 Europe Agmatine Market Outlook, By Health & Beauty Stores (2021-2030) ($MN)
  • Table 37 Europe Agmatine Market Outlook, By Third-party Online Channels (2021-2030) ($MN)
  • Table 38 Europe Agmatine Market Outlook, By Other Sales Channels (2021-2030) ($MN)
  • Table 39 Europe Agmatine Market Outlook, By Application (2021-2030) ($MN)
  • Table 40 Europe Agmatine Market Outlook, By Supplements & Neutraceuticals (2021-2030) ($MN)
  • Table 41 Europe Agmatine Market Outlook, By Pharmaceutical (2021-2030) ($MN)
  • Table 42 Europe Agmatine Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 43 Asia Pacific Agmatine Market Outlook, By Country (2021-2030) ($MN)
  • Table 44 Asia Pacific Agmatine Market Outlook, By Form (2021-2030) ($MN)
  • Table 45 Asia Pacific Agmatine Market Outlook, By Capsules (2021-2030) ($MN)
  • Table 46 Asia Pacific Agmatine Market Outlook, By Powder (2021-2030) ($MN)
  • Table 47 Asia Pacific Agmatine Market Outlook, By Sales Channel (2021-2030) ($MN)
  • Table 48 Asia Pacific Agmatine Market Outlook, By Specialty Stores (2021-2030) ($MN)
  • Table 49 Asia Pacific Agmatine Market Outlook, By Drug Stores (2021-2030) ($MN)
  • Table 50 Asia Pacific Agmatine Market Outlook, By Health & Beauty Stores (2021-2030) ($MN)
  • Table 51 Asia Pacific Agmatine Market Outlook, By Third-party Online Channels (2021-2030) ($MN)
  • Table 52 Asia Pacific Agmatine Market Outlook, By Other Sales Channels (2021-2030) ($MN)
  • Table 53 Asia Pacific Agmatine Market Outlook, By Application (2021-2030) ($MN)
  • Table 54 Asia Pacific Agmatine Market Outlook, By Supplements & Neutraceuticals (2021-2030) ($MN)
  • Table 55 Asia Pacific Agmatine Market Outlook, By Pharmaceutical (2021-2030) ($MN)
  • Table 56 Asia Pacific Agmatine Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 57 South America Agmatine Market Outlook, By Country (2021-2030) ($MN)
  • Table 58 South America Agmatine Market Outlook, By Form (2021-2030) ($MN)
  • Table 59 South America Agmatine Market Outlook, By Capsules (2021-2030) ($MN)
  • Table 60 South America Agmatine Market Outlook, By Powder (2021-2030) ($MN)
  • Table 61 South America Agmatine Market Outlook, By Sales Channel (2021-2030) ($MN)
  • Table 62 South America Agmatine Market Outlook, By Specialty Stores (2021-2030) ($MN)
  • Table 63 South America Agmatine Market Outlook, By Drug Stores (2021-2030) ($MN)
  • Table 64 South America Agmatine Market Outlook, By Health & Beauty Stores (2021-2030) ($MN)
  • Table 65 South America Agmatine Market Outlook, By Third-party Online Channels (2021-2030) ($MN)
  • Table 66 South America Agmatine Market Outlook, By Other Sales Channels (2021-2030) ($MN)
  • Table 67 South America Agmatine Market Outlook, By Application (2021-2030) ($MN)
  • Table 68 South America Agmatine Market Outlook, By Supplements & Neutraceuticals (2021-2030) ($MN)
  • Table 69 South America Agmatine Market Outlook, By Pharmaceutical (2021-2030) ($MN)
  • Table 70 South America Agmatine Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 71 Middle East & Africa Agmatine Market Outlook, By Country (2021-2030) ($MN)
  • Table 72 Middle East & Africa Agmatine Market Outlook, By Form (2021-2030) ($MN)
  • Table 73 Middle East & Africa Agmatine Market Outlook, By Capsules (2021-2030) ($MN)
  • Table 74 Middle East & Africa Agmatine Market Outlook, By Powder (2021-2030) ($MN)
  • Table 75 Middle East & Africa Agmatine Market Outlook, By Sales Channel (2021-2030) ($MN)
  • Table 76 Middle East & Africa Agmatine Market Outlook, By Specialty Stores (2021-2030) ($MN)
  • Table 77 Middle East & Africa Agmatine Market Outlook, By Drug Stores (2021-2030) ($MN)
  • Table 78 Middle East & Africa Agmatine Market Outlook, By Health & Beauty Stores (2021-2030) ($MN)
  • Table 79 Middle East & Africa Agmatine Market Outlook, By Third-party Online Channels (2021-2030) ($MN)
  • Table 80 Middle East & Africa Agmatine Market Outlook, By Other Sales Channels (2021-2030) ($MN)
  • Table 81 Middle East & Africa Agmatine Market Outlook, By Application (2021-2030) ($MN)
  • Table 82 Middle East & Africa Agmatine Market Outlook, By Supplements & Neutraceuticals (2021-2030) ($MN)
  • Table 83 Middle East & Africa Agmatine Market Outlook, By Pharmaceutical (2021-2030) ($MN)
  • Table 84 Middle East & Africa Agmatine Market Outlook, By Other Applications (2021-2030) ($MN)